Clinical TrialsMedicare | Clinical TrialsPrivate Insurance | Medicare Payment FDA | Cancer Research | Stem Cell Research | Privacy | Other |
||||
LETTER TO SENATORS SPECTER AND HARKIN April 5, 2000 The Honorable Arlen
Specter, Chair The Honorable Tom
Harkin Dear Senators Specter and Harkin: The undersigned organizations, representing individuals with cancer and their caregivers, lend their enthusiastic support to your amendment to increase domestic discretionary spending by $1.6 billion in order to facilitate a $2.7 billion boost in National Institutes of Health (NIH) funding. We commend you for your leadership on NIH appropriations, and we will strongly urge your colleagues to vote for the amendment. Biomedical research holds the key to improved prevention, diagnosis, and treatment of cancer. For those who are diagnosed with cancer and their families, research is our lifeline. Our nation's investment in research is yielding impressive results; important basic science discoveries are answering fundamental questions about human disease and being translated into improved treatments. Unless NIH funding is increased, research progress will slow and promising research endeavors may be abandoned. Even with the recent boosts in NIH appropriations, strong research proposals are going unfunded. We appreciate the strong commitment Congress has made to NIH, but we do not want to see the movement toward doubling the NIH budget halt now. Therefore, we will send a strong message to the Senate to support the Specter-Harkin amendment. Cancer Leadership Council American
Cancer Society Contact: About CLC | What's New | Policy
Issues | Participants' Login Copyright
© 2001-2002 Cancer Leadership Council. All rights reserved. |